Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kaniwa

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Chemical & Pharmaceutical Bulletin|September 1, 1985
Bioavailability of pyridoxal phosphate from enteric-coated tablets. I. Apparent critical dissolution pH and bioavailability of commercial products in humansN Kaniwa, H Ogata, N Aoyagi, et al.
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|March 31, 1999
[Validation of dissolution testing: evaluation of vibration levels of dissolution apparatuses]N Kaniwa, N Katori, N Aoyagi, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1985
Bioavailability of pyridoxal phosphate from enteric-coated tablets. III. Correlations between bioavailability in humans and beagle dogs and between bioavailability in humans and in vitro dissolution ratesN Kaniwa, H Ogata, N Aoyagi, et al.
Journal of Pharmaceutical Sciences|October 1, 1982
Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humansN Aoyagi, H Ogata, N Kaniwa, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1983
The bioavailability of flufenamic acid and its dissolution rate from capsulesN Kaniwa, H Ogata, N Aoyagi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1982
Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humansH Ogata, N Aoyagi, N Kaniwa, et al.
British Journal of Cancer|March 19, 2009
Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patientsH Ueno, N Kaniwa, T Okusaka, et al.
The Pharmacogenomics Journal|September 14, 2011
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patientsM Tohkin, N Kaniwa, Y Saito, et al.
The Pharmacogenomics Journal|December 24, 2008
A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studiesY Sato, N M Laird, K Nagashima, et al.
The Pharmacogenomics Journal|November 30, 2005
Haplotype structures of the UGT1A gene complex in a Japanese populationM Saeki, Y Saito, H Jinno, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Chemical & Pharmaceutical Bulletin|September 1, 1985
Bioavailability of pyridoxal phosphate from enteric-coated tablets. I. Apparent critical dissolution pH and bioavailability of commercial products in humansN Kaniwa, H Ogata, N Aoyagi, et al.
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|March 31, 1999
[Validation of dissolution testing: evaluation of vibration levels of dissolution apparatuses]N Kaniwa, N Katori, N Aoyagi, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1985
Bioavailability of pyridoxal phosphate from enteric-coated tablets. III. Correlations between bioavailability in humans and beagle dogs and between bioavailability in humans and in vitro dissolution ratesN Kaniwa, H Ogata, N Aoyagi, et al.
Journal of Pharmaceutical Sciences|October 1, 1982
Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humansN Aoyagi, H Ogata, N Kaniwa, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1983
The bioavailability of flufenamic acid and its dissolution rate from capsulesN Kaniwa, H Ogata, N Aoyagi, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1982
Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humansH Ogata, N Aoyagi, N Kaniwa, et al.
British Journal of Cancer|March 19, 2009
Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patientsH Ueno, N Kaniwa, T Okusaka, et al.
The Pharmacogenomics Journal|September 14, 2011
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patientsM Tohkin, N Kaniwa, Y Saito, et al.
The Pharmacogenomics Journal|December 24, 2008
A new statistical screening approach for finding pharmacokinetics-related genes in genome-wide studiesY Sato, N M Laird, K Nagashima, et al.
The Pharmacogenomics Journal|November 30, 2005
Haplotype structures of the UGT1A gene complex in a Japanese populationM Saeki, Y Saito, H Jinno, et al.
Pageof 6